Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Neuroscience ; 170(1): 67-77, 2010 Sep 29.
Article in English | MEDLINE | ID: mdl-20620192

ABSTRACT

Accumulating evidence indicate that the neuropeptide urotensin II and urotensin II receptors are expressed in subsets of mammal spinal motoneurons. In fact, a role for the peptide in the regulation of motoneuron function at neuromuscular junction has been suggested, while roles for urotensin II at central synapses in spinal cord have never been addressed. We found that urotensin II receptors were closely associated with cholinergic terminals apposed to a subset of motoneuron and non-motoneuron cell bodies in the ventral horn of the adult mouse cervical spinal cord; urotensin II receptor was also expressed on non-cholinergic nerve terminals. In particular, urotensin II receptor appeared associated with both large cholinergic C-boutons and standard cholinergic terminals contacting some motoneuron perikarya. Cholinergic nerve terminals from mouse cervical spinal cord were equipped with functional presynaptic urotensin II receptors linked to excitation of acetylcholine release. In fact, functional experiments conducted on cervical spinal synaptosomes demonstrated a urotensin II evoked calcium-dependent increase in [(3)H]acetylcholine release pharmacologically verified as consistent with activation of urotensin II receptors. In spinal cord these actions would facilitate cholinergic transmission. These data indicate that, in addition to its role at the neuromuscular junction, urotensin II may control motor function through the modulation of motoneuron activity within the spinal cord.


Subject(s)
Acetylcholine/metabolism , Cervical Vertebrae , Presynaptic Terminals/metabolism , Receptors, G-Protein-Coupled/metabolism , Spinal Cord/metabolism , Urotensins/physiology , Animals , Male , Mice , Motor Neurons/drug effects , Motor Neurons/metabolism , Neuromuscular Junction/cytology , Neuromuscular Junction/drug effects , Neuromuscular Junction/metabolism , Presynaptic Terminals/drug effects , Quinolines/pharmacology , Receptors, G-Protein-Coupled/agonists , Spinal Cord/drug effects , Urea/analogs & derivatives , Urea/pharmacology , Urotensins/antagonists & inhibitors
2.
Microsc Res Tech ; 70(5): 452-8, 2007 May.
Article in English | MEDLINE | ID: mdl-17393494

ABSTRACT

In the last decade, fluorescence resonance energy transfer (FRET) has become a useful technique for studying intermolecular interactions applied to the analysis of biological systems. Although FRET measurements may be very helpful in the comprehension of different cellular processes, it can be difficult to obtain quantitative results, hence the necessity of studying FRET on controllable systems. Here, a fuzzy nanostructured system called a nanocapsule is presented as a nanometric-device allowing distance modulation, thus preserving photophysical properties of fluorescent dyes and exhibiting good potential features for improving quantitative FRET analysis. We evaluated the behavior of such a sample using four FRET methods (three of them based on steady-state fluorescence and one using lifetime measurements). Within some limitations that can be overcome, these nanodevices have the potential to serve as a benchmark system for characterizing new FRET couples and to develop quantitative approaches for FRET analysis.

SELECTION OF CITATIONS
SEARCH DETAIL
...